RS
RPRX icon

Rakuten Securities’s Royalty Pharma RPRX Stock Holding History

Rakuten Securities’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.5K Buy
561
+554
+7,914% +$28.8K 0.01% 316
2026
Q1 		$336 Sell
7
-94
-93% -$4.12K ﹤0.01% 772
2025
Q4 		$3.9K Sell
101
-35
-26% -$1.33K ﹤0.01% 556
2025
Q3 		$4.8K Buy
136
+37
+37% +$1.34K ﹤0.01% 523
2025
Q2 		$3.57K Sell
99
-543
-85% -$18K ﹤0.01% 529
2025
Q1 		$20K Sell
642
-986
-61% -$31.3K 0.01% 316
2024
Q4 		$41.5K Buy
1,628
+1,003
+160% +$26.6K 0.02% 224
2024
Q3 		$17.7K Sell
625
-639
-51% -$17.7K 0.01% 279
2024
Q2 		$33.3K Buy
1,264
+193
+18% +$5.35K 0.01% 210
2024
Q1 		$32.5K Sell
1,071
-2,847
-73% -$83.9K 0.01% 222
2023
Q4 		$110K Buy
+3,918
New +$108K 0.09% 117

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rakuten Securities's RPRX Position: Q2 2026 in Review

Rakuten Securities increased its Royalty Pharma (RPRX) stake by 7,914% in Q2 2026, buying an estimated $28.8K and bringing the position to 561 shares worth $31.5K. The position accounts for 0.01% of the portfolio, ranked #316.

Rakuten Securities first reported a position in RPRX in Q4 2023 and has held it in 11 quarters since. The position peaked at $110K in Q4 2023. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Rakuten Securities held 561 shares of Royalty Pharma worth $31.5K as of Q2 2026.
  • Rakuten Securities bought 554 Royalty Pharma shares in Q2 2026, an estimated $28.8K.
  • Royalty Pharma made up 0.01% of Rakuten Securities's portfolio in Q2 2026, its #316 holding.
  • Rakuten Securities first reported a position in Royalty Pharma in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Royalty Pharma position peaked at $110K in Q4 2023.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.